Today, laparoscopic surgery in patients with uterine cancer has firmly taken its place in the treatment of this disease. This has been favored by a number of factors, such as the rapid development of gynecologic endoscopic surgery that permits practically any operation for benign genital diseases to be performed laparoscopically, as well as the increase in the number of patients with overweight, diabetes, hypertension, and another obvious somatic disease that is accompanied by the increased rate of complications during open surgery and that causes one to look for new surgical solutions for its reduction. This solution in patients with cancer of the uterine corpus and metabolic syndrome is laparoscopic extirpation of the uterus and its appendages with or without pelvic lymphadenectomy.